SCICLONE PHARMACEUTICALS INC 4
4 · SCICLONE PHARMACEUTICALS INC · Filed Aug 22, 2013
Insider Transaction Report
Form 4
Yin Min
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2013-08-20$4.23/sh+12,500$52,875→ 12,500 total - Sale
Common Stock
2013-08-20$5.50/sh−12,500$68,750→ 0 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2013-08-20−12,500→ 12,500 totalExercise: $4.23Exp: 2021-11-01→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]Granted under the Issuer's 2005 Equity Incentive Plan.
- [F2]The Options vested 100% based on the achievement of certain peformance targets achieved prior to December 31, 2013.